(Reuters) -Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for ...
A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...
Der er parkeringsplads lige bag biografen (Smedegades P-plads). Lørdag og søndag er der parkering uden tidsbegrænsning. Alle andre dage kan man holde der tre timer i tidsrummet 8-18. Kommer man efter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results